Related Experiment Video
Updated: Jun 23, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Late prosthetic valve endocarditis: review of 19 cases and treatment
Insights
Combined medical and surgical therapy significantly improves survival rates for patients with late prosthetic valve endocarditis, particularly those with Staphylococcus epidermidis infections.
Area of Science:
- Cardiology
- Infectious Diseases
- Surgical Innovation
Background:
- Late prosthetic valve endocarditis (PVE) is a serious complication following valve replacement surgery.
- Staphylococcus epidermidis is a frequent causative agent in PVE.
- Outcomes for PVE have historically been challenging.
Purpose of the Study:
- To evaluate the efficacy of different treatment strategies for late prosthetic valve endocarditis.
- To compare medical management versus combined medical and surgical therapy for PVE.
- To identify predictors of survival in patients with PVE.
Main Methods:
- Retrospective analysis of 19 episodes of late PVE in 18 patients treated between 1971 and 1979.
- Patients were divided into two groups: medical therapy (Group I) and combined medical-surgical therapy (Group II).
- Causative organisms and patient outcomes, including survival rates, were analyzed.
Main Results:
- Staphylococcus epidermidis was identified in two-thirds of cases.
- Medical therapy alone resulted in a 22.2% long-term survival rate.
- Combined medical and surgical therapy led to a 100% survival rate post-reoperation, with 60% alive at a mean of three years.
Conclusions:
- Combined medical and surgical therapy offers superior outcomes for late prosthetic valve endocarditis.
- Prompt surgical intervention is crucial in cases of PVE with systemic emboli, evolving murmurs, uncontrolled sepsis, or heart failure.
- Aggressive treatment is especially vital when fungal or staphylococcal infections are implicated.
Abstract:
Eighteen out of 1606 patients treated by valve replacement between January 1971 to June 1979 were admitted in Brugmann University Hospital for late prosthetic valve endocarditis. Of the 19 episodes (one patient had two distinct episodes four years apart), nine (group I) were treated medically and 10 (group II) by combined medical and surgical therapy. The infective organism was Staphylococcus epidermidis in two-thirds of our cases. Two cases in group I (22.2%) were long-term survivors. In group II, all 10 patients survived reoperation. There were four late deaths; six patients (60%) were still alive 1.8 to 4.4 years later (mean survival three years). Prompt prosthetic valve replacement is recommended in the presence of systemic emboli, evolving murmurs, uncontrolled sepsis or congestive heart failures (especially if the infective organism is a fungus or a staphylococcus), in late prosthetic valve endocarditis.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management

